Delivery Order SPE2DB22D1106-SPE2DB24FDMG4

Award Date 11/17/23
Potential Completion Date 11/20/23
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, and has a ceiling value of $1,352.72. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. This award is associated...
The U.S. Defense Logistics Agency (DLA) awarded a $1,899.09 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564717803 - NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,406.70 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a prescription pharmaceutical product. The award has an ultimate completion date of May 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAROPIN 0.2% 40 MG/20 ML VIAL 20ML, a medical product, with a ceiling value of $1,903.47 and a performance period ending on January 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,099.88 firm fixed-price contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, with a completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a local anesthetic medication. The contract has a ceiling value of $4,450.59 and is a firm fixed price delivery order, with a completion date of August 13, 2024. The contract is not set aside for any special business category. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRBJ7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,523.20 delivery order is for the supply of the pharmaceutical product NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract has a firm fixed price and an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, at a firm fixed price of $1,558.98. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside...
This federal contract award is for the delivery of NAROPIN 0.2% 400 MG/200 ML BTL 200ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract, valued at $5,214.94, was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a delivery order contract with a firm fixed price pricing type. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563539837 NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $5,221.35. The contract is a firm fixed-price delivery order that runs through February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs)...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDMG4
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.42, is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023.

This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. That IDC is valued at up to $999,999,999.00 and runs through December 31, 2025, serving as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award reviewed does not have any set-aside designation, indicating open competition.

Generated 5/12/25, 10:23 AM